According to WiseGuy Reports, the Acid Lactase Market Size was valued at USD 800 million in 2024 and remained at USD 800 million in 2025, with the market projected to reach USD 1.5 billion by 2035 at a CAGR of 5.9% during 2026–2035. Growth is being supported by rising demand for lactose-free products, increasing awareness of lactose intolerance, greater consumer focus on digestive health, advances in enzyme production, and expanding applications across food and beverage industries. Major companies profiled include Chr. Hansen, DuPont, Cargill, Novozymes, DSM, Meiji Holdings, Genencor, AB Enzymes, BASF, Rohm and Haas, and Amano Enzyme.

Market Overview

Acid lactase is an enzyme used to break down lactose and support the development of products designed for consumers with lactose digestion challenges. Its functional role has made it increasingly relevant to food manufacturers, dietary supplement producers, pharmaceutical companies, and other businesses developing products focused on digestive health.

The market is segmented according to source, form, application, end use, and geography. Microbial fermentation, plant extraction, and animal sources represent the primary source categories, while products are available in powder, liquid, granule, and tablet forms.

Food and beverage represents a major application area, while pharmaceuticals and nutraceuticals provide additional avenues for growth. The technology is particularly relevant to lactose-free and reduced-lactose product development.

Market Size Reached in 2025

The market stood at approximately USD 800 million in 2025, unchanged from the reported 2024 valuation. Demand is supported by continued interest in lactose-free food and beverage products and growing awareness of digestive health.

Food manufacturers are increasingly developing alternatives for consumers who experience difficulty digesting lactose. Acid lactase can support the formulation and processing of these products, making enzyme technology relevant across dairy-related and other food applications.

The dietary supplements segment is also becoming an important opportunity. Consumers are paying greater attention to digestive wellness, creating demand for products designed to support dietary management and nutritional needs.

Expected Market Size by 2035

The market is projected to reach USD 1.5 billion by 2035. Expansion is expected to come from the growing availability of lactose-free products, pharmaceutical applications, nutraceutical development, and continued innovation in enzyme production.

Food companies are likely to continue expanding lactose-free product portfolios as consumer preferences become more diversified. This can create additional opportunities for enzyme suppliers serving dairy and food-processing manufacturers.

Pharmaceutical and nutraceutical applications offer another source of long-term growth. Increasing attention to digestive health can encourage the development of specialized formulations containing enzyme-based solutions.

Market CAGR

The Acid Lactase Market is forecast to grow at a CAGR of 5.9% from 2026 to 2035. This pace reflects rising consumer awareness together with improvements in enzyme production and expanding commercial applications.

Advances in fermentation and enzyme processing technologies can help manufacturers improve product consistency, scalability, and suitability for different applications. These developments can support broader commercial adoption.

Key Growth Drivers

The rising demand for lactose-free products is one of the strongest market drivers. Food manufacturers are expanding their product offerings to accommodate consumers seeking reduced-lactose or lactose-free alternatives.

Growing awareness of lactose intolerance is reinforcing this trend. As more consumers become familiar with dietary approaches to lactose sensitivity, demand for suitable food products and related solutions can increase.

Digestive health is another important factor. Greater consumer interest in nutrition and wellness is creating opportunities for nutraceutical and dietary supplement applications.

Technological improvements in enzyme production are also supporting the industry. More efficient production processes can improve supply capabilities and enable manufacturers to address increasingly specialized requirements.

Emerging Market Trends

The growth of lactose-free food and beverage products is reshaping the enzyme market. Dairy alternatives and modified dairy products are increasingly being developed to meet varied dietary preferences.

Nutraceutical applications are also expanding. Enzymes are gaining attention within the broader digestive health category as consumers seek targeted nutritional solutions.

Product formats are becoming more diversified. Powder, liquid, granule, and tablet forms provide manufacturers with flexibility in formulation, processing, storage, and end-use applications.

Sourcing technology is another area of development. Microbial fermentation offers scalable production potential and can support consistent enzyme manufacturing for commercial applications.

Competitive Landscape

The competitive landscape includes established enzyme manufacturers, chemical companies, and biotechnology-focused suppliers. Chr. Hansen, DuPont, Cargill, Novozymes, DSM, Meiji Holdings, Genencor, AB Enzymes, BASF, Rohm and Haas, and Amano Enzyme are among the companies profiled.

Participants compete through enzyme quality, production efficiency, formulation expertise, research capabilities, application support, and global distribution.

Product innovation remains an important competitive factor as manufacturers seek solutions suitable for food processing, supplements, pharmaceuticals, and emerging digestive health applications. Companies that can combine consistent enzyme performance with scalable production and technical support are positioned to benefit from the market's projected expansion toward USD 1.5 billion by 2035.